UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma

Clinical cancer research, 2013-09, Vol.19 (17), p.4559-4563

2013

Volltextzugriff (PDF)

Issues in Using Progression-Free Survival When Evaluating Oncology Products

Journal of clinical oncology, 2009-06, Vol.27 (17), p.2874-2880

2009

Volltextzugriff (PDF)

U.S. Food and Drug Administration Approval Summary: Omacetaxine Mepesuccinate as Treatment for Chronic Myeloid Leukemia

The oncologist (Dayton, Ohio), 2014-01, Vol.19 (1), p.94-99

2014

Volltextzugriff (PDF)

Design and Analysis of Non-Inferiority Trials

1, 2016

Volltextzugriff (PDF)

Finding the (biomarker-defined) subgroup of patients who benefit from a novel therapy: No time for a game of hide and seek

Clinical trials (London, England), 2023-08, Vol.20 (4), p.341-350

2023

Volltextzugriff (PDF)

Continuing Reassessment of the Risks of Erythropoiesis-Stimulating Agents in Patients with Cancer

Clinical cancer research, 2008-06, Vol.14 (11), p.3242-3247

2008

Volltextzugriff (PDF)

U.S. Food and Drug Administration Approval: Ruxolitinib for the Treatment of Patients with Intermediate and High-Risk Myelofibrosis

Clinical cancer research, 2012-06, Vol.18 (12), p.3212-3217

2012

Volltextzugriff (PDF)

U.S. Food and Drug Administration Approval: Ofatumumab for the Treatment of Patients with Chronic Lymphocytic Leukemia Refractory to Fludarabine and Alemtuzumab

Clinical cancer research, 2010-09, Vol.16 (17), p.4331-4338

2010

Volltextzugriff (PDF)

Innovations in Pediatric Therapeutics Development: Principles for the Use of Bridging Biomarkers in Pediatric Extrapolation

Therapeutic innovation & regulatory science, 2023-01, Vol.57 (1), p.109-120

2023

Volltextzugriff (PDF)

Some essential considerations in the design and conduct of non-inferiority trials

Clinical trials (London, England), 2011-08, Vol.8 (4), p.432-439

2011

Volltextzugriff (PDF)

U.S. Food and Drug Administration Approval: Rituximab in Combination with Fludarabine and Cyclophosphamide for the Treatment of Patients with Chronic Lymphocytic Leukemia

The oncologist (Dayton, Ohio), 2011-01, Vol.16 (1), p.97-104

2011

Volltextzugriff (PDF)

Testing in a Prespecified Subgroup and the Intent-to-Treat Population

Drug information journal, 2012-03, Vol.46 (2), p.175-179

2012

Volltextzugriff (PDF)

Inferences on a life distribution by sampling from the ages or the ages at death

Lifetime data analysis, 2006-09, Vol.12 (3), p.305-323

Rothmann, Mark D

2006

Volltextzugriff (PDF)

Missing Data in Biologic Oncology Products

Journal of biopharmaceutical statistics, 2009-11, Vol.19 (6), p.1074-1084

2009

Volltextzugriff (PDF)

On Non-inferiority Analysis Based On Delta-method Confidence Intervals

Journal of biopharmaceutical statistics, 2003-08, Vol.13 (3), p.565-583

2003

Volltextzugriff (PDF)

Statement on P-values

Statistics in biopharmaceutical research, 2021-02, Vol.13 (1), p.57-58

2021

Volltextzugriff (PDF)

Stability of maxima over randomly deleted sets

Statistics & probability letters, 1997-12, Vol.36 (2), p.145-152

Rothmann, Mark D.

1997

Volltextzugriff (PDF)

Stochastic processes involving random deletion

Journal of applied probability, 2001-03, Vol.38 (1), p.95-107

2001

Volltextzugriff (PDF)

Weak convergence on randomly deleted sets

Journal of applied probability, 1998-12, Vol.35 (4), p.893-902

1998

Volltextzugriff (PDF)

A Law of Large Numbers on Randomly Deleted Sets

The Annals of applied probability, 1997-02, Vol.7 (1), p.170-182

1997

Volltextzugriff (PDF)

Persistent convergence on randomly deleted sets

Statistics & probability letters, 1994-08, Vol.20 (5), p.367-373

1994

Volltextzugriff (PDF)

A series criterion for moving maxima

Stochastic processes and their applications, 1993-06, Vol.46 (2), p.241-247

1993

Volltextzugriff (PDF)

Strong limiting bounds for a sequence of moving maxima

Statistics & probability letters, 1991-05, Vol.11 (5), p.403-410

1991

Volltextzugriff (PDF)

Maximal divergent uniform spacings

Stochastic processes and their applications, 1989-10, Vol.33 (1), p.175-183

1989

Volltextzugriff (PDF)

Estimation of weighted multinomial probabilities under log-convex constraints

Journal of statistical planning and inference, 1999-10, Vol.81 (1), p.1-11

1999

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Aktive Filter

ThemaBiology, Life Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(40)

Publikationsform

Sprache

Englisch
(42)

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Life Sciences & Biomedicine
(22)
Humans
(16)
Mathematics
(14)
Physical Sciences
(14)
Statistics & Probability
(12)
United States
(9)
United States Food And Drug Administration
(9)
Drug Approval
(8)
Female
(8)
Oncology
(8)
Biological And Medical Sciences
(7)
Medical Sciences
(7)
Antineoplastic Agents
(6)
Exact Sciences And Technology
(6)
Male
(6)
Pharmacology. Drug Treatments
(6)
Probability And Statistics
(6)
Random Deletion
(6)
Sciences And Techniques Of General Use
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma

Issues in Using Progression-Free Survival When Evaluating Oncology Products

U.S. Food and Drug Administration Approval Summary: Omacetaxine Mepesuccinate as Treatment for Chronic Myeloid Leukemia

Design and Analysis of Non-Inferiority Trials

Finding the (biomarker-defined) subgroup of patients who benefit from a novel therapy: No time for a game of hide and seek

Continuing Reassessment of the Risks of Erythropoiesis-Stimulating Agents in Patients with Cancer

U.S. Food and Drug Administration Approval: Ruxolitinib for the Treatment of Patients with Intermediate and High-Risk Myelofibrosis

U.S. Food and Drug Administration Approval: Ofatumumab for the Treatment of Patients with Chronic Lymphocytic Leukemia Refractory to Fludarabine and Alemtuzumab

Innovations in Pediatric Therapeutics Development: Principles for the Use of Bridging Biomarkers in Pediatric Extrapolation

Some essential considerations in the design and conduct of non-inferiority trials

U.S. Food and Drug Administration Approval: Rituximab in Combination with Fludarabine and Cyclophosphamide for the Treatment of Patients with Chronic Lymphocytic Leukemia

Testing in a Prespecified Subgroup and the Intent-to-Treat Population

Inferences on a life distribution by sampling from the ages or the ages at death

Missing Data in Biologic Oncology Products

On Non-inferiority Analysis Based On Delta-method Confidence Intervals

Statement on P-values

Stability of maxima over randomly deleted sets

Stochastic processes involving random deletion

Weak convergence on randomly deleted sets

A Law of Large Numbers on Randomly Deleted Sets

Persistent convergence on randomly deleted sets

A series criterion for moving maxima

Strong limiting bounds for a sequence of moving maxima

Maximal divergent uniform spacings

Estimation of weighted multinomial probabilities under log-convex constraints

Aktive Filter

Suchergebnisse filtern